ADVANZ PHARMA is a UK-headquartered pharmaceutical company with a strategic focus on specialty and hospital pharmaceuticals in Europe and Canada that is comitted to improve the lives of patients by providing and enhancing the medicines they depend on.
- Agile and experienced team, including direct sales, marketing and medical capability across many of Europe’s major markets and a global distribution network
- Broad expertise in several therapeutic areas with particular strengths in the critical care, anti-infectives, endocrinology, cardiovascular and more broadly on rare disease medicines, particularly in hepatology and gastroenterology
Vision & Outlook
Further grow the position as a partner of choice for specialty and hospital pharmaceuticals in Europe and beyond.
Invest in a strengthened platform to accelerate the company’s pipeline of innovative specialty pharmaceutical products.
Highlights & Updates
Aquisition of the majority of Intercept Pharmaceutical's subsidiaries and operations in Europe, Canada, and all other markets outside of the U.S in 2022.
Combination more than doubles ADVANZ PHARMA’s commercial and medical team with sizable additions across major EU countries.
EUR 510 million